New Kit Enables Automation of DNA Cloning on the BioXp® System Beginning from Linear DNA, Further Expanding the Utility, Speed, and Impact of the BioXp® Automated Molecular Biology Workstation SAN DIEGO, May 22, 2023 (GLOBE NEWSWIRE) — Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology

LambdaTest provides an enterprise execution environment for organizations undergoing rapid digital transformation. Backed by Telstra Ventures, LambdaTest addresses the growing demand for secure and compliant test execution infrastructure within their private cloud. San Francisco, May 22, 2023 (GLOBE NEWSWIRE) — LambdaTest, a leading intelligent digital experience testing cloud, announced that its

Leading mobile brokerage continues to innovate to meet the evolving needs of retail investors NEW YORK, May 22, 2023 (GLOBE NEWSWIRE) — Webull, a leading commission-free trading platform, is proudly celebrating its five-year anniversary. Since May 2018, Webull has offered its users professional level tools and analytics while creating an

Meltwater expands on 20 years of robust AI capabilities with integration of OpenAI models and advanced algorithms to deliver insights, moving away from the time and guesswork needed to make sense of billions of pieces of online data. SAN FRANCISCO, May 22, 2023 (GLOBE NEWSWIRE) — Meltwater, a global leader

San Jose, CA, May 22, 2023 (GLOBE NEWSWIRE) — Codex Labs, a Silicon Valley bio-skintech company, and Paula Simpson, nutricosmetics formulator, author and microbiome expert, recently announced the addition of Paula to the Codex Labs medical advisory board. “As we delve deeper into skin-gut-brain integrative wellness solutions, we are excited

May 22, 2023 Amsterdam, the Netherlands and Nashville, TN, USA – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Vanderbilt University Medical Center (VUMC), home to the top-ranked adult and pediatric hospitals in the Southeastern U.S., today announced a collaboration that aims to reduce the

Novel JEL™ Technology for Periocular Administration COSTA MESA, Calif., May 22, 2023 (GLOBE NEWSWIRE) — AiViva Biopharma Inc., a clinical-stage biotechnology company, announced that it has begun a Phase 1 trial and completed dosing the first cohort of patients diagnosed with wet age-related macular degeneration (wAMD), and/or diabetic macular edema